Changes in the gastrointestinal mucosa after radio- and chemotherapy of the neoplasms
Journal Title: OncoReview - Year 2012, Vol 2, Issue 1
Abstract
Gastrointestinal mucositis induced by radio- and chemotherapy of the neoplasms is associated with morphological changes in the mucosa of the alimentary tract. The pain, ulceration, nausea, vomiting and diarrhea are the effect of the damage of the mucus secretion, decreased goblet cells and changes in the microflora of the mucosa. Over the last years, investigators defined the basic molecular mechanisms of the mucosal barrier injury. Sonis et al. presented the model of the five phases: initiation, upregulation with generation of messengers, signaling and amplification, ulceration with inflammation and healing. The toxic agent (radiation and chemotherapy) play a key role in the described model of mucositis. The liberating reactive oxygen species (ROS) start a cascade of events. ROS directly damage cells, tissues and blood vessels. In subsequent phases plays a crucial role a nuclear factor κB (NF-κB) and increased local production of proinflammatory cytokines IL-1β, IL-6 and Tumor Necrosis Factor (TNF). Then the role of COX-2 is a hallmark in the initiation of inflammation and activation of matrix metaloproteina. In an earlier stage a damage of the submucosa, and next a injury of mucosa are observed. From a clinical point of view, it is important to stage ulcers due to the penetration of bacteria to the small blood vessels leading to sepsis. Healing phase after 2 to 4 weeks, the severity of the changes after radiation or chemotherapy. Clinical symptoms and morphological changes caused by radiation and chemotherapy for cancer are at an early split in the form of acute radiation- induced reactions produced up to 3−6 months.
Authors and Affiliations
Anna Nasierowska-Guttmejer
Keywords
Related Articles
- EP ID EP53138
- DOI -
- Views 221
- Downloads 0
Breast cancer heterogeneity - report from IMPAKT Breast Cancer Conference
On 2–4 May 2013, in Brussels took place the 5th IMPAKT conference on translational research in breast cancer. The most important issue raised during the conference was the phenomenon of breast cancer heterogeneity, both...
Zaawansowany mięsak maziówkowy o długotrawałym przebiegu - opis przypadku i przegląd pismiennictwa
Postęp w leczeniu systemowym przerzutowego raka nerki związany jest z rejestracją nowych leków. Przyniosło to poprawę wyników leczenia, ale zmusza również do dokonywania wyboru leku. Decyzja ta jest szczególnie istotna w...
Planning hormonal therapy in prostate cancer patients – expert view
In last decades prostate cancer became one of the most common cancers in the World, and one of the most common cancer death diagnosis. As a hormone-dependent entity for almost 70 years prostate cancer is treated with hor...
Bezpieczeństwo kardiologiczne podczas stosowania sunitinibu i sorafenibu, wielokinazowych inhibitorów angiogenezy
Kardiotoksyczność wielokinazowych inhibitorów angiogenezy, sunitinibu i sorafenibu, objawia się najczęściej w postaci dysfunkcji skurczowej mięśnia sercowego oraz tętniczych i żylnych zdarzeń zakrzepowo-zatorowych. Istot...
Spotkanie z człowiekiem
W pracy onkologa szczególnie często mamy do czynienia z problemami zmuszającymi nas do trudnych wyborów i podejmowania decyzji, które mają nie tylko wymiar kliniczny, ale może przede wszystkim etyczny. Niestety, zbyt mał...